Biolife solutions named in biospace best places to work in biopharma 2023 report

Only 60 companies selected – based on 2,000 respondents bothell, wash. , nov. 17, 2022 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs) ("biolife" or the "company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (cgt) and the broader biopharma markets, today announced that it has been selected for inclusion in the biospace best places to work in biopharma 2023 report.
BLFS Ratings Summary
BLFS Quant Ranking